Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Takeda Pharmaceutical Company (TAK)

NYSE:TAK

TAK

Takeda Pharmaceutical Company

RESEARCH TOOLSreports

Takeda Pharmaceutical Company (TAK) Ratios

Compare

1,347 Followers

Takeda Pharmaceutical Company Ratios

TAK's free cash flow for Q3 2025 was ¥0.54. For the 2025 fiscal year, TAK's free cash flow was decreased by ¥ and operating cash flow was ¥0.22. See a summary of the company’s cash flow.

Ratios	TTM	Mar 25	Mar 24	Mar 23	Mar 22
Liquidity Ratios
Current Ratio	1.19	1.01	1.11	0.97	1.21
Quick Ratio	0.65	0.52	0.58	0.57	0.81
Cash Ratio	0.25	0.15	0.20	0.21	0.40
Solvency Ratio	0.11	0.12	0.10	0.13	0.11
Operating Cash Flow Ratio	0.43	0.42	0.31	0.39	0.52
Short-Term Operating Cash Flow Coverage	1.92	1.93	1.95	2.88	5.51
Net Current Asset Value	¥ -4.65T	¥ -4.79T	¥ -5.28T	¥ -5.21T	¥ -4.90T
Leverage Ratios
Debt-to-Assets Ratio	0.31	0.32	0.32	0.31	0.33
Debt-to-Equity Ratio	0.64	0.65	0.67	0.69	0.76
Debt-to-Capital Ratio	0.39	0.39	0.40	0.41	0.43
Long-Term Debt-to-Capital Ratio	0.36	0.36	0.38	0.39	0.42
Financial Leverage Ratio	2.02	2.05	2.08	2.20	2.32
Debt Service Coverage Ratio	1.32	1.67	3.35	2.69	3.40
Interest Coverage Ratio	1.26	2.49	201.49	4.19	3.76
Debt to Market Cap	0.53	0.63	0.75	0.65	0.80
Interest Debt Per Share	3.30K	1.45K	1.55K	1.45K	1.43K
Net Debt to EBITDA	3.14	3.41	3.83	3.00	2.95
Profitability Margins
Gross Profit Margin	59.49%	65.51%	66.43%	69.11%	68.99%
EBIT Margin	12.79%	9.80%	11.71%	15.39%	16.81%
EBITDA Margin	29.97%	26.42%	26.83%	31.88%	33.15%
Operating Profit Margin	10.28%	7.48%	5.02%	12.18%	12.91%
Pretax Profit Margin	4.60%	3.82%	1.24%	9.31%	8.48%
Net Profit Margin	2.53%	2.36%	3.38%	7.87%	6.45%
Continuous Operations Profit Margin	2.54%	2.36%	3.38%	7.87%	6.45%
Net Income Per EBT	54.99%	61.64%	272.90%	84.52%	76.03%
EBT Per EBIT	44.75%	51.11%	24.66%	76.47%	65.66%
Return on Assets (ROA)	0.73%	0.76%	0.95%	2.27%	1.75%
Return on Equity (ROE)	1.58%	1.56%	1.98%	4.99%	4.05%
Return on Capital Employed (ROCE)	3.59%	2.92%	1.67%	4.27%	4.18%
Return on Invested Capital (ROIC)	1.89%	1.72%	1.63%	3.51%	3.12%
Return on Tangible Assets	1.84%	2.04%	2.66%	6.47%	4.65%
Earnings Yield	1.24%	1.51%	2.22%	4.67%	4.22%
Efficiency Ratios
Receivables Turnover	5.89	6.32	6.11	5.91	4.93
Payables Turnover	3.87	5.12	4.47	4.05	3.74
Inventory Turnover	1.29	1.30	1.18	1.26	1.30
Fixed Asset Turnover	2.14	2.33	2.14	2.38	2.25
Asset Turnover	0.29	0.32	0.28	0.29	0.27
Working Capital Turnover Ratio	6.94	35.22	52.80	22.13	5.14
Cash Conversion Cycle	251.59	267.72	286.63	260.99	257.84
Days of Sales Outstanding	61.96	57.78	59.72	61.78	74.08
Days of Inventory Outstanding	283.99	281.18	308.49	289.42	281.35
Days of Payables Outstanding	94.37	71.25	81.58	90.20	97.59
Operating Cycle	345.96	338.96	368.21	351.20	355.43
Cash Flow Ratios
Operating Cash Flow Per Share	710.55	329.27	228.94	314.84	359.16
Free Cash Flow Per Share	589.53	266.73	75.30	110.67	299.67
CapEx Per Share	121.02	62.54	153.64	204.18	59.49
Free Cash Flow to Operating Cash Flow	0.83	0.81	0.33	0.35	0.83
Dividend Paid and CapEx Coverage Ratio	2.23	2.10	0.93	1.07	2.39
Capital Expenditure Coverage Ratio	5.87	5.26	1.49	1.54	6.04
Operating Cash Flow Coverage Ratio	0.23	0.23	0.15	0.22	0.26
Operating Cash Flow to Sales Ratio	0.25	0.23	0.17	0.24	0.31
Free Cash Flow Yield	10.22%	11.96%	3.63%	5.06%	17.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	80.68	66.33	45.02	21.41	23.68
Price-to-Sales (P/S) Ratio	2.04	1.56	1.52	1.69	1.53
Price-to-Book (P/B) Ratio	1.19	1.03	0.89	1.07	0.96
Price-to-Free Cash Flow (P/FCF) Ratio	9.78	8.36	27.53	19.77	5.81
Price-to-Operating Cash Flow Ratio	8.12	6.77	9.05	6.95	4.85
Price-to-Earnings Growth (PEG) Ratio	0.35	-2.57	-0.82	0.55	-0.61
Price-to-Fair Value	1.19	1.03	0.89	1.07	0.96
Enterprise Value Multiple	9.95	9.33	9.50	8.28	7.56
Enterprise Value	13.31T	11.29T	10.87T	10.64T	8.94T
EV to EBITDA	9.95	9.33	9.50	8.28	7.56
EV to Sales	2.98	2.46	2.55	2.64	2.51
EV to Free Cash Flow	14.29	13.18	46.14	30.97	9.54
EV to Operating Cash Flow	11.86	10.68	15.18	10.89	7.96
Tangible Book Value Per Share	-1.03K	-629.15	-770.48	-871.79	-813.17
Shareholders’ Equity Per Share	4.84K	2.16K	2.32K	2.05K	1.82K
Tax and Other Ratios
Effective Tax Rate	0.45	0.38	-1.73	0.15	0.24
Revenue Per Share	2.83K	1.43K	1.36K	1.30K	1.14K
Net Income Per Share	71.49	33.61	46.04	102.14	73.57
Tax Burden	0.55	0.62	2.73	0.85	0.76
Interest Burden	0.36	0.39	0.11	0.61	0.50
Research & Development to Revenue	0.16	0.16	0.17	0.16	0.15
SG&A to Revenue	0.00	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	<0.01	0.02	0.02	0.02	0.01
Income Quality	9.92	9.80	4.97	3.08	4.88

Currency in JPY